IBS lowers QOL, increases costs in the UK

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.371, 2002-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alosetron improves QOL in IBS

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 308, 2001-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Paroxetine, psychotherapy improve QOL in IBS

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 406, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Tegaserod improves QOL, cost effective in IBS

Inpharma, Vol. 1, Iss. 1468, 2004-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Meaningful QOL gains with alosetron in women with IBS-D

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 660, 2012-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Tegaserod improves QOL, cost effective in IBS

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 468, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite